Search
-
Holly Furlong: Gender rights and the Women's Museum of Ireland
https://le.ac.uk/museum-studies/study/graduate-profiles/holly-furlong
After graduating from Museum Studies at Leicester in 2014, Holly Furlong has gone onto a variety of roles within the museum sector.
-
University of Leicester Insight Events
https://staffblogs.le.ac.uk/careerdevelopmentservice/2015/10/12/insight-events/
Posted by Marie Muir in Career Development Service on October 12, 2015 Imagine your dream role…mine is the Marketing Director of England Netball.
-
Research and teaching staff
https://le.ac.uk/respiratory-sciences/people/research-and-teaching-staff
Contact details for our research and teaching staff.
-
2018 news
https://le.ac.uk/dbs/news/2018
Browse news relating to the Division of Biomedical Services from 2018.
-
Business Law
https://le.ac.uk/modules/2026/lw1002
Module code: LW1002 Law impacts on every stage of the life of a business, how you set it up, run operations and close it down.
-
Business Law
https://le.ac.uk/modules/2025/lw1002
Module code: LW1002 Law impacts on every stage of the life of a business, how you set it up, run operations and close it down.
-
Communicating Molecular Genetics Research
https://le.ac.uk/modules/2025/mb7213
Module code: MB7213 You will learn how to communicate effectively various types of molecular genetic research to a range of audiences, in addition to expanding your laboratory and analytical skills.
-
Communicating Molecular Genetics Research
https://le.ac.uk/modules/2026/mb7213
.
-
New academy aims to change nature of health care for older people
https://le.ac.uk/news/2016/april/new-academy-aims-to-change-nature-of-health-care-for-older-people
A new academy has been set up in Leicester that hopes to tackle the challenges of ageing and change the nature of health care for older people.
-
New blood cancer study announces outstanding results
https://le.ac.uk/news/2017/april/outstanding-results-announce-from-new-blood-cancer-study
Scientists have described new results of a blood cancer study as ‘outstanding’ in tackling previously untreatable forms of chronic lymphocytic leukaemia (CLL).